Published online May 15, 2019. doi: 10.4239/wjd.v10.i5.304
Peer-review started: March 20, 2019
First decision: April 13, 2019
Revised: April 18, 2019
Accepted: May 1, 2019
Article in press: May 1, 2019
Published online: May 15, 2019
Processing time: 58 Days and 19.5 Hours
Screening for gestational diabetes in high risk women during pregnancy is undertaken with oral glucose tolerance test (OGTT). This paper is an observational study auditing the prevalence of significant hypoglycaemia on the screening OGTT during pregnancy and exploring its impact on the birth weight, if any association with low birth weight (LBW). Currently those women identified as with hypoglycaemia on OGTT do not have any additional antenatal monitoring. Any association of such hypoglycaemia noted on the screening OGTT with LBW might help in targeting antenatal care in such women towards improving pregnancy outcomes.
The results of our study support allocation of resources for antenatal monitoring of women noted to have hypoglycaemia, especially the Asian ethnic cohort who appeared to be at higher risk of having babies with low birth-weight.
This study was undertaken to determine the prevalence of hypoglycaemia on the OGTT during screening for gestation diabetes in high risk women and explore any association with fetal birth weight.
We audited data on all woman deemed high risk and had the screening OGTT during pregnancy identifying 3537 women who met the criteria and had the required complete data for analysis. Having defined hypoglycaemia (blood glucose ≤ 3.5 mmol/L) and categorizing birth weight as low (≤ 2500 g), normal (2500 to 4499 g) or Macrosomia (≥ 4500 g) we analysed the prevalence of hypoglycaemia on the OGTT screening and its association with birth weight using ANOVA to compare group means and logistic regression analysis to assess the factors independently predicting the low birth-weight.
In this audit on 3537 women deemed high risk as per NICE criteria and who had the OGTT screening, the proportion who has hypoglycaemia was 3.7%, majority of the hypoglycaemia being on the 2-h plasma glucose (2-h PG) value. 2.7% women had babies with LBW and this cohort had significantly lower fasting glucose (4.3 ± 0.6 mmol/L, P = 0.001) and a higher proportion of this cohort had 2-h PG ≤ 3.5 mmol/L compared to the cohorts with normal and macrosomic babies (8.3% vs 2.8% vs 4.2%; P = 0.007). The factors which predicted LBW were fasting plasma glucose, Asian ethnicity and 2-h PG ≤ 3.5 mmol/L. Maternal age, 2-h PG ≥ 7.8 mmol/L and HbA1c were not significant predictors of LBW.
We observed the prevalence of hypoglycaemia in the screening OGTT during pregnancy to be about 3.7%. Such hypoglycaemia appears to be independently associated with risk of fetal LBW, and Asian ethnic origin being another risk factor for fetal low birth.
This study on a large cohort of high risk women may improve awareness amongst clinicians about the potential impact of hypoglycaemia on birth weight and potentially help in considering assessment of fetal weight with serial growth scans as a part of antenatal care towards improving pregnancy outcomes. Future studies incorporating other risk factors associated with the fetal birth weight and studies looking at resource implications to implement the required fetal growth monitoring for such at-risk women with hypoglycaemia would be recommended.